| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3316 | |||||||||||||||||||||||
| Submitter : | Mr. Lawrence Douglas | Date & Time: | 12/15/2006 08:12:31 | |||||||||||||||||||||
| Organization : | Mr. Lawrence Douglas | |||||||||||||||||||||||
| Category : | Drug Industry | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I do not approve of and will not support the use of fetal tissue or embryonic stem cells in the preparation of any drug or vaccine.
If such preparations do become available, I will not use them. I will actively encourage others to avoid their use, and I will encourage them to seek out and use alternatives. Our government and our public corporations should not be profiting from the deaths of the innocent. | ||||||||||||||||||||||||